Concepedia

Alkylating Agent Regimens

Alkylating Agent Regimens is a therapeutic strategy in hematologic malignancies that involves the structured administration of alkylating agents—cytotoxic compounds inducing DNA crosslinking—to eradicate malignant cells through timed, dose-intensified cycles distinguished by their specific drug combinations, sequencing, and treatment schedules.

168

Publications

9.9K

Citations

1K

Authors

326

Institutions

Publications per year

2017–2026

11

Parents

Publications

168

Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.

Pauline Brice, Y Bastion, Éric Lepage et al. · Journal of Clinical Oncology · 1997 · 641 citations

, , +13

Effects of Treatment on Fertility in Long-Term Survivors of Childhood or Adolescent Cancer

Mulvihill Jj, Connelly Rr, Naughton et al. · New England Journal of Medicine · 1987 · 510 citations

, , +17

Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer

Ronald Reimer, Robert N. Hoover, Joseph F. Fraumeni et al. · New England Journal of Medicine · 1977 · 453 citations

, , +16

Effects of Combined Drug Therapy on Metastatic Cancer of the Testis

Min C. Li · JAMA · 1960 · 413 citations

, , +17

Alkylating agents in bronchogenic carcinoma

Robert A. Green, Edward Humphrey, Henry Close et al. · The American Journal of Medicine · 1969 · 354 citations

, , +12

1–5 of 168

Authors

1K

  1. SL
    Stanton L. Gerson

    Case Western Reserve University, United States

    5 publications · 161 citations

    5

    h-index

  2. MC
    Morton Coleman

    Cornell University, United States

    4 publications · 206 citations

    4

    h-index

  3. FJ
    Francis J. Giles

    The University of Texas MD Anderson Cancer Center, United States

    4 publications · 197 citations

    4

    h-index

  4. MA
    Morie A. Gertz

    Mayo Clinic, United States

    4 publications · 229 citations

    4

    h-index

  5. BA
    Beverly A. Teicher

    Dana-Farber Cancer Institute, United States

    4 publications · 270 citations

    4

    h-index

1–5 of 1K

Institutions

326

  1. Dana-Farber Cancer Institute

    Boston, United States

    10 h-index

    38 publications

    1.4K citations

  2. The University of Texas MD Anderson Cancer Center

    Houston, United States

    6 h-index

    43 publications

    1.6K citations

  3. National Cancer Institute

    Bethesda, United States

    6 h-index

    22 publications

    5.4K citations

  4. University of Bologna

    Bologna, Italy

    5 h-index

    5 publications

    86 citations

  5. National Institutes of Health

    Bethesda, United States

    5 h-index

    27 publications

    9.4K citations

  6. Case Western Reserve University

    Cleveland, United States

    4 h-index

    5 publications

    188 citations

  7. Mayo Clinic

    Rochester, United States

    4 h-index

    12 publications

    413 citations

  8. Washington University in St. Louis

    St Louis, United States

    4 h-index

    6 publications

    350 citations

1–8 of 326

Venues

  1. PubMed

    Repository · 32 publications · 1.3K citations

    17

    h-index

  2. Journal of Clinical Oncology

    15 publications · 1.8K citations

    14

    h-index

  3. Cancer

    15 publications · 727 citations

    14

    h-index

  4. American Journal of Hematology

    AJH · 7 publications · 323 citations

    7

    h-index

  5. JAMA

    5 publications · 745 citations

    5

    h-index

1–5